Phenylalanine-induced leucopenia in genetic and dichloroacetic acid generated deficiency of glutathione transferase Zeta

Biochemical Pharmacology

Volumn 77, Issue 8, 2009, Pages 1358-1363

  Theodoratos, Angelo ^a   Tu, Wen Juan ^a   Cappello, Jean ^a   Blackburn, Anneke C ^a   Matthaei, Klaus ^a   Board, Philip G ^a  

^a Biology and Environment   (Australia)

Author keywords

Dichloroacetic acid; Glutathione transferase Zeta; GSTZ1 1 deficiency; Maleylacetoacetate isomerase; Maleylacetone cytotoxicity; Phenylalanine induced leucopenia

Indexed keywords

DICHLOROACETIC ACID; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ZETA 1; PHENYLALANINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME DEFICIENCY; GLUTATHIONE TRANSFERASE ZETA DEFICIENCY; LEUKOCYTE; LEUKOPENIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; DICHLOROACETATE; ERYTHROCYTE COUNT; GLUTATHIONE; GLUTATHIONE TRANSFERASE; LEUKOCYTE COUNT; LEUKOCYTES; LEUKOPENIA; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHENYLALANINE; SPLEEN;

EID: 62549085099     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.01.017     Document Type: Article

References (27)

1. Board P.G., Baker R.T., Chelvanayagam G., and Jermiin L.S. Zeta a novel class of glutathione transferases in a range of species from plants to humans. Biochem J 328 (1997) 929-935
2. Fernandez-Canon J.M., Hejna J., Reifsteck C., Olson S., and Grompe M. Gene structure, chromosomal location, and expression pattern of maleylacetoacetate isomerase. Genomics 58 (1999) 263-269
3. Fernandez-Canon J.M., Baetscher M.W., Finegold M., Burlingame T., Gibson K.M., and Grompe M. Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. Mol Cell Biol 22 (2002) 4943-4951
4. Lim C.E., Matthaei K.I., Blackburn A.C., Davis R.P., Dahlstrom J.E., Koina M.E., et al. Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases. Am J Pathol 165 (2004) 679-693
5. Blackburn A.C., Matthaei K.I., Lim C., Taylor M.C., Cappello J.Y., Hayes J.D., et al. Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways. Mol Pharmacol 69 (2006) 650-657
6. Cornett R., James M.O., Henderson G.N., Cheung J., Shroads A.L., and Stacpoole P.W. Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity. Biochem Biophys Res Commun 262 (1999) 752-756
7. Lantum H.B., Cornejo J., Pierce R.H., and Anders M.W. Perturbation of maleylacetoacetic acid metabolism in rats with dichloroacetic acid-induced glutathione transferase zeta deficiency. Toxicol Sci 74 (2003) 192-202
8. Tong Z., Board P.G., and Anders M.W. Glutathione transferase zeta catalyses the oxygenation of the carcinogen dichloroacetic acid to glyoxylic acid. Biochem J 331 (1998) 371-374
9. Tong Z., Board P.G., and Anders M.W. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids. Chem Res Toxicol 11 (1998) 1332-1338
10. Tzeng H.F., Blackburn A.C., Board P.G., and Anders M.W. Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate. Chem Res Toxicol 13 (2000) 231-236
11. Anderson W.B., Liebler D.C., Board P.G., and Anders M.W. Mass spectral characterization of dichloroacetic acid-modified human glutathione transferase zeta. Chem Res Toxicol 15 (2002) 1387-1397
12. Guo X., Dixit V., Liu H., Shroads A.L., Henderson G.N., James M.O., et al. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal. Drug Metab Dispos 34 (2006) 36-42
13. Boorman G.A. Drinking water disinfection byproducts: review and approach to toxicity evaluation. Environ Health Perspect 107 1 (1999) 207-217
14. Krasner S.W., McGuire M.J., Jacangelo J.G., Patania N.L., Reagan K.M., and Aieta E.M. The occurrence of disinfection by-products in U.S. drinking water. J Am Waterworks Assoc 81 (1989) 41-53
15. Bull R.J., Sanchez I.M., Nelson M.A., Larson J.L., and Lansing A.J. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology 63 (1990) 341-359
16. DeAngelo A.B., Daniel F.B., Most B.M., and Olson G.R. The carcinogenicity of dichloroacetic acid in the male Fischer 344 rat. Toxicology 114 (1996) 207-221
17. DeAngelo A.B., George M.H., and House D.E. Hepatocarcinogenicity in the male B6C3F1 mouse following a lifetime exposure to dichloroacetic acid in the drinking water: dose-response determination and modes of action. J Toxicol Environ Health A 58 (1999) 485-507
18. Stacpoole P.W., Gilbert L.R., Neiberger R.E., Carney P.R., Valenstein E., Theriaque D.W., et al. Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate. Pediatrics 121 (2008) e1223-e1228
19. Felitsyn N., Stacpoole P.W., and Notterpek L. Dichloroacetate causes reversible demyelination in vitro: potential mechanism for its neuropathic effect. J Neurochem 100 (2007) 429-436
20. Bonnet S., Archer S.L., Allalunis-Turner J., Haromy A., Beaulieu C., Thompson R., et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11 (2007) 37-51
21. Seltzer S. Purification and properties of maleylacetone cis-trans isomerase from vibrio 01. J Biol Chem 248 (1973) 215-222
22. Baker M.A., Cerniglia G.J., and Zaman A. Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples. Anal Biochem 190 (1990) 360-365
23. Anderson W.B., Board P.G., Gargano B., and Anders M.W. Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids. Chem Res Toxicol 12 (1999) 1144-1149
24. Lindblad B., and Steen G. Identification of 4,6-dioxoheptanoic acid (succinylacetone)3,5-dioxooctanedioic acid (succinylacetoacetate) and 4-oxo-6-hydroxyheptanoic acid in the urine from patients with hereditary tyrosinemia. Biomed Mass Spectrom 9 (1982) 419-424
25. Tschudy D.P., Hess R.A., Frykholm B.C., and Blaese R.M. Immunosuppressive activity of succinylacetone. J Lab Clin Med 99 (1982) 526-532
26. Grenier A., Lescault A., Laberge C., Gagne R., and Mamer O. Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia. Clin Chim Acta 123 (1982) 93-99
27. Beutler E., Mathai C.K., and Smith J.E. Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease. Blood 31 (1968) 131-150